Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China

Roche logo

Roche

Status

Completed

Conditions

Non-Small Cell Lung Cancer, Lung Cancer, Cancer

Treatments

Other: No intervention

Study type

Observational

Funder types

Industry

Identifiers

NCT02458651
YO29443

Details and patient eligibility

About

The purpose of this observational study is to describe patient and disease characteristics as well as treatment patterns in Chinese patients with unresectable stage IIIB or IV non-small cell lung cancer (NSCLC). In addition, this study characterizes the clinical outcomes for various populations of patients defined by clinical and tumor characteristics, treatment patterns, and hospital category defined by city tier and geographic region.

Enrollment

1,378 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Histologically/cytologically confirmed, unresectable Stage IIIB or IV non-small cell lung cancer (NSCLC)
  • Received at least one anti-cancer treatment targeting unresectable Stage IIIB or IV NSCLC in the study site after study initiation
  • Radiographic evidence of disease

Exclusion criteria

  • Prior systematic treatment for unresectable Stage IIIB or IV non-small cell lung cancer (NSCLC)
  • Participation in any anti-cancer, regimen-specified clinical study of first-line treatment for unresectable Stage IIIB or IV NSCLC.

Trial design

1,378 participants in 6 patient groups

Tier 1 and North
Description:
Site as described by tier level of the city where the site is located and by geographical location: Tier 1 city in northern region of China
Treatment:
Other: No intervention
Tier 1 and South
Description:
Site as described by tier level of the city where the site is located and by geographical location: Tier 1 city in southern region of China
Treatment:
Other: No intervention
Tier 2 and Middle
Description:
Site as described by tier level of the city where the site is located and by geographical location: Tier city in middle region of China
Treatment:
Other: No intervention
Tier 2 and North
Description:
Site as described by tier level of the city where the site is located and by geographical location: Tier 2 city in northern region of China
Treatment:
Other: No intervention
Tier 2 and South Eastern
Description:
Site as described by tier level of the city where the site is located and by geographical location: Tier 2 city in south eastern region of China
Treatment:
Other: No intervention
Tier 2 and South Western
Description:
Site as described by tier level of the city where the site is located and by geographical location: Tier 2 city in south western region of China
Treatment:
Other: No intervention

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems